Y Intercept (Hong Kong) LTD Perkinelmer Inc Transaction History

Y Intercept (Hong Kong) LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	N/A	7,052 New	7,052 $853,000
Q3 2023 Nov 14, 2023	BUY	$115.88 - $122.81 $612,309 - $648,928	5,284 New	5,284 $639,000
Q4 2022 Feb 14, 2023	BUY	$119.0 - $147.98 $403,172 - $501,356	3,388 Added 127.61%	6,043 $847,000
Q3 2022 Feb 14, 2023	BUY	$118.07 - $160.96 $73,321 - $99,956	621 Added 30.53%	2,655 $319,000
Q2 2022 Aug 08, 2022	BUY	$134.91 - $172.49 $269 - $344	2 Added 0.1%	2,034 $289,000
Q1 2022 May 16, 2022	BUY	$162.31 - $192.2 $329,813 - $390,550	2,032 New	2,032 $355,000
Q4 2021 Feb 14, 2022	SELL	$166.66 - $201.06 $1.31 Million - $1.58 Million	-7,840 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$151.98 - $190.5 $1.19 Million - $1.49 Million	7,840 New	7,840 $1.36 Million
Q1 2021 May 12, 2021	SELL	$120.35 - $160.53 $430,251 - $573,894	-3,575 Closed	0 $0
Q4 2020 Feb 05, 2021	BUY	$122.05 - $147.91 $436,328 - $528,778	3,575 New	3,575 $503,000

576

108M

57.1K

23.1K

Ticker PKI
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 126,224,000
Market Cap $15.3B
Description
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detectio...

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.